Study links topical fluorouracil with higher risk for type of basal cell carcinoma

12/3/2013 | Medscape (free registration)

Treatment with fluorouracil appears to be associated with a greater chance of developing morpheaform basal cell carcinoma among people who have already had skin cancer, according to a study in JAMA Dermatology. An analysis of data from the Veterans Affairs Topical Tretinoin Chemoprevention study found that use of topical 5-fluorouracil did not increase the risk of other forms of BCC.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX